How do we know if digital mental health solutions are effective?

The latest stories trending on MedCity News.

Editor's Pick

Top Story How Do We Know If Digital Mental Health Solutions Are Effective? There are several ways to know if a digital mental health solution is working, including whether it has proven clinical outcomes or if it's improving access to care, executives said during a panel discussion. Sponsored Content A Personalized Approach to Medication Nonadherence Presented by MedCity News & Abarca Health At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes. Learn More. Sponsored Content Heard at HLTH 2023: PurpleLab Presented by PurpleLab PurpleLab CEO, Mark Brosso on real world evidence and what they provide for clinical trials. Watch Now

Featured News

How to Leverage the Patient Journey for Market Strategy Development A hearing healthcare veteran consultant, who has significant hearing loss, describes 7 market-tested best practices. Understanding the consumer-patient journey is crucial to developing strategic priorities for companies across hearing healthcare, from hearing aids to cochlear implants to gene/drug therapy. Cytovale Snags $84M To Commercialize Early Sepsis Detection Test Cytovale, a San Francisco-based medical diagnostics company, raised $84 million in Series C funds to advance the commercialization of its diagnostic test for early sepsis detection. Using standard blood draws, the test provides results in under 10 minutes. It is meant to detect sepsis in patients who present to hospital emergency departments. AdventHealth CEO's 3 Rules For Employee Retention At a conference last week, AdventHealth CEO Terry Shaw discussed how his organization fosters a culture in which its workers feel heard and supported. Some of his advice included making necessary changes based on employee feedback and providing ample opportunities for career advancement. Gilead's $285M Confidence Vote for Next-Gen Cancer Med & New Cell Therapy Tech Gilead Sciences is increasing its stake in partner Arcellx and expanding the cell therapy alliance the companies started in 2022. The deal expands the lead partnered program to more cancers and gives Gilead a chance at another Arcellx cell therapy candidate made with different technology. Funding to Improve Drug Availability Government funding plays a major role in the advancement of drugs, including monoclonal antibodies, which are extremely expensive to produce and can take months to develop. Medtech's iPhone Moment: Pioneering Patient Experience-Focused Design in Medical Devices Flexible, portable medical diagnostic devices are the future, augmenting equity and access to quality healthcare. That means designing for patients as well as caregivers, creating devices that are intuitive, easy to use, and easily adaptable to various environments.

Resources

MedCity Pivot Podcast: A Conversation with CommonSpirit Health's Population Health Innovation Lead Season 4 of the MedCity Pivot Podcast launches with a focus on health equity and a conversation with Dr. Alisahah Jackson, system vice president of population health innovation and policy at CommonSpirit Health. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe